Lara Vojnov, PhD is a global health scientist and strategist with over two decades of expertise in infectious disease diagnostics, pandemic preparedness, and health systems strengthening. She is a Senior Scholar at the Center for Global Health Policy and Politics of Georgetown University and serves as Chief Scientist at the Global Health Impact Group, providing strategic and technical assistance to leading organizations including the World Health Organization, Gates Foundation, Médecins Sans Frontières, Unitaid, Clinton Health Access Initiative, and others.
From 2016 to 2023, Dr. Vojnov served as Diagnostics Advisor in WHO’s Global HIV, Hepatitis and STI Programme, supporting 190+ member states through development of core guidelines and recommendations. While at WHO, she was seconded to support the COVID-19 pandemic, mpox outbreak, and Pandemic Fund advisory work. Before joining WHO, she was a Senior Scientist at the Clinton Health Access Initiative focused on diagnostic access. She is currently Co-Chair of the Lancet Commission on Societal Resilience in a New Pandemic Age and a member of WHO’s Strategic Advisory Group of Experts on In Vitro Diagnostics and WHO’s Global Validation Advisory Committee (GVAC).
Dr. Vojnov holds a PhD in Cellular and Molecular Pathology from the University of Wisconsin-Madison and has authored over 70 peer-reviewed publications. She is a Deputy Editor of the Journal of the International AIDS Society.
